Company: INMB
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001213900-25-033742
Chunk: 31

Company: Inmune Bio, Inc.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 31
---
 members or persons associated with a member. Family Relationships There are no family relationships among and between the issuer’s directors, officers, persons nominated or chosen by the issuer to become directors or officers, or beneficial owners of more than ten percent of any class of the issuer’s equity securities. 21 Anti -Hedging , Pledging and Insider Trading Policy As part of our insider trading policy, our officers, directors, employees and consultants are prohibited from engaging in short sales of our securities and our officers, directors and employees are prohibited from engaging in hedging transactions involving our securities. Our insider trading policy further prohibits officers, directors and employees from pledging securities as collateral for a loan unless pre -clearedby the compliance officer for the insider trading policy. A copy of the insider trading policy is filed as Exhibit 19.1 to our Annual Report on Form 10 -Kfor the fiscal year ended December 31, 2024. Clawback Policy Our Board of Directors has adopted a Policy for Recovery of Erroneously Awarded Compensation (the “Clawback Policy”) that is applicable to our current and former executive officers, and such other of our senior executive team as may be determined. If we determine that we must restate our financial results as reported in a periodic or other report filed with the SEC to correct an accounting error due to material noncompliance with any financial reporting requirement under the U.S. securities laws, our Board of Directors must recover all incentive compensation, both cash and equity -based, awarded or paid to an executive officer covered by the Clawback Policy to the extent any such compensation would not have been awarded or paid to such officer based on the restated financial results during the three completed fiscal years preceding the date on which the Company is required to prepare the restatement. A copy of the Clawback Policy is filed as Exhibit 99.7 to our Annual Report on Form 10 -Kfor the fiscal year ended December 31, 2023. Policies and Practices Related to the Timing of Option Awards The Company generally grants annual equity -basedawards during the first half of the calendar year, although such timing may change from year to year. The compensation committee also may consider and approve interim or mid -yeargrants, or grants made on another basis, from time to time based on business needs, changing compensation practices or other factors, in the discretion of the compensation committee.The compensation committee does not take into account material nonpublic information in determining the timing and terms of equity -basedawards, and the